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Gout and Pseudogout
Gilbert B. Bluhm, MD*

L j o u t has been established as a disease of antiquity, but
pseudogout from past times must yet be recognized from
human remains,

Gout is known to be associated with hyperuricemia and the
presence of sodium monourate crystals within the joint^ as
well as in some other tissues of the body. Pseudogout is not
known to be associated regularly with a measurable metabolic defect, but it is often associated w i t h articular
chondrocalcinosis which results from the deposition of
calcium pyrophosphate dihydrate (GPPD) crystals (Figure 1).

A historical review of gout parallels the history of medicine.
The first clinical description was recorded as early as 2500
B.C. During examination of an Egyptian mummy in 1952,
Kettridge and Downs discovered a urinary calculus that
dated back to 7,000 years ago. The calculus contained a
urate crystalline nidus which was believed to be due to
gout.'' Hippocrates noted that gout occurs primarily in men,
but not before puberty. By the first century A.D., the use of
colchicine to treat attacks of arthritis was known. By the
second century A.D,, the hereditary aspect of gout was
appreciated. The interrelationship between gout and uric
acid metabolism was recognized in the sixteenth century,
and a century later gout was distinguished from other types
of arthritis as we now understand them. Many seventeenth
century paintings illustrate the agony of clinical gout by
depicting an obese male whose hand clutches a goblet of
wine while he is atrestwith a bandaged, swollen foot that is
elevated and protected. Meanwhile, the devil, spear in
hand, stands close by the affected extremity.
There are many historical accounts of notable individuals —
kings, artists, scientists and philosophers—who suffered
with gout, among them Alexander the Great, Michelangelo,
Benjamin Franklin, Charles Darwin, and Samuel Johnson,^
In contrast, pseudogout as a distinct entity has been reported
only in the last 20 years+ and has not yet been identified in
antiquity. Both gout and pseudogout are now considered to
be crystalline deposition diseases, a term first popularized
by McCarty, et a/," because chemically different crystals
were identified regularly in the synovial fluid and exudative
leucocytes during attacks of arthritis.

Fig.1
This x-ray of a hand from a patient w i t h pseudogout illustrates the
calcification in the articular disc at the distal ulna (solid arrow) and the
line of calcification in the articular cartilage (open arrow) due to
deposition of CPPD crystals. Chondrocalcinosis may be seen regularly
in the joints of patients w i t h pseudogout.
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Fig. 2
Illustrated are the synovial fluid findings from a patient with gout. The acicular crystals of sodium monourate were viewed by compensated polarized
light microscopy (X768). With a first order red retaitlation plate for compensation, these crystals can be identified as negatively birefringent, thus
consistent with the diagnosis of gout. The key is to align the long axis of the crystal either parallel or perpendicular to the slow component of the
compensator. When the long axis of the sodium monourate crystal is parallel to the wave direclion of the slow component the crystal appears yellow;
but when perpendicular, il is blue, the characlerislics of a negatively birefringent crystal. The calcium pyrophosphate dihydrate crystals found wilh
pseudogout are positively birefringent and when parallel to lhe slow componeni Ihey are blue; when perpendicular, Ihey become yellow. (Color
illuslrations of lhe CPM resulls have previously been reporied by lhe author.')

an elevated serum urate level and presenting with a family
history of gout), or one who is between attacks of acute
arthritis (Stage II), would most likely show no morbid
evidence on which the diagnosis of gout could be established by the paleopathologist or physical anthropologist.
However, in Stage III, residual indirect evidence, depicted
by x-ray as a "punched out" cystic bone lesion produced by
a urate tophus eroding the cortex of the bone, may be
present.^ Urate deposits are radiolucent (Figure 4). Collections of sodium monourate crystals in a tophus appear
grossly as achalk-like material, but more specific identification is made only by compensated polarizing microscopy or
by demonstration that these crystals are digestible with
uricase. Tophaceous urate deposits may occur in soft tissue
sites outside the anatomical confines of a j o i n t . The

In an acute attack of gout or pseudogout, the responsible
crystal is present and may be detected with appropriate
methods of light microscopy Because the two crystalline
types are easily distinguished from each other by compensated polarizing microscopy, specific crystal identification
in the synovial fluid establishes whether an observed acute
or chronic arthritis is due to gout or pseudogout.^ The
sodium monourate crystal is typically acicular and negatively birefringent, whereas the CPPD crystal is pleomorphic
and positively birefringent (Figure 2 and 3).
Primary gout
asymptomatic
critical) acute
arthritis (Stage

is categorized clinically into three stages:
hyperuricemia (Stage I), intermittent (interarthritis (Stage II), and chronic tophaceous
111).^ An individual in Stage I (exhibiting only
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Fig. 3
The synovial fluid sample is from the knee joint of a palienl wilh chondrocalcinosis and an acule attack of pseudogout. The exudative
leucocytes have engulfed numerous pleomorphic crystals of calcium pyrophosphate dihydrate. This topographical photo was oblained
by interference phase contrast lighl microscopy (X768).

olecranon bursa is a favorite area of deposition, as are the
prepatellar bursa, helix of the ear, and areas aboutthe distal
joints of the hands and feet.

should be useful for the paleopathologist. If there are
collections of crystals or pieces of material in a joint that
seem foreign to the area, a small sample can be evaluated by
x-ray diffraction and the pattern obtained can be used to
establish their identity. The A m e r i c a n Society for
Crystallography in Washington, D.C. maintains thousands
of x-ray diffraction patterns of crystalline compounds to aid
in identifying unknown samples.

Pseudogout, as the name implies, mimics the clinical onset
and course of arthritis due to gout. In pseudogout direct
evidence o f t h e disease process may be observed in x-ray
films as a line of calcification in the articular cartilage^
(Figure 1). In establishing the diagnosis of chondrocalcinosis
appropriate sites to screen by x-ray arethe wrists, knees, and
pelvis. The tophaceous collections of CPPD crystals in
pseudogout occur in articular cartilage. Thus far, these
deposits have not been demonstrated outside the joint, in
contrast with gouL

There are other clinical considerations about gout and
pseudogout that may be helpful to note. In gout, men are
affected after puberty, and men outnumber women 20 to 1.
Generally, women who are affected with gout are past the
age of menopause unless there is an unusual familial
tendency. Pseudogout, in contrast, may affect men of
women equally, and symptoms usually begin afterthe ageof
40. Some studies of chondrocalcinosis suggest a familial
occurrence that is primarily evident in female members of
the family. Two other diseases apparently unrelated to each
other but known to be associated with chondrocalcinosis
and pseudogout are h y p e r p a r a t h y r o i d i s m and hema-'
chromatosis.

Calcified collections due to other calcium salts, such as
calcium diphosphate and calcium apatite crystals, have
been found to occur about tendons, especially near the
shoulder, and in the meniscus o f a knee.
To identify calcified deposits as CPPD crystals, x-ray diffraction can be used. This is a well established technique and

16

Bluhm

Fig. 4
A radiograph of the forefoot obtained from a palienl with tophaceous
gouty arthritis (Stage lii). Nole the increased swelling of lhe soft tissue
and loss of lhe cortex of lhe bone of lhe greal loe al the bunion area,
due lo lhe deposition of urate.
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